Global ePRO, E-Patient Diaries and eCOA Strategic Business Report 2024: Market to Reach $4.7 Billion by 2030 - Rise in Clinical Trials Drives Demand - ResearchAndMarkets.com

Vaccine
DUBLIN--(BUSINESS WIRE)--The "ePRO, E-Patient Diaries and eCOA - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
'ePRO, E-Patient Diaries and eCOA - Global Strategic Business Report'
Global ePRO, E-Patient Diaries and eCOA Market to Reach $4.7 Billion by 2030
The global market for ePRO, E-Patient Diaries and eCOA estimated at US$1.6 Billion in the year 2022, is projected to reach a revised size of US$4.7 Billion by 2030, growing at a CAGR of 14.7% over the analysis period 2022-2030.
eClinical Outcome Assessments (eCOAs), one of the segments analyzed in the report, is projected to record a 14.9% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Epatient Reported Outcomes (epros) segment is estimated at 16.4% CAGR for the next 8-year period.
The U.S. Market is Estimated at $561.4 Million, While China is Forecast to Grow at 17.5% CAGR
The ePRO, E-Patient Diaries and eCOA market in the U.S. is estimated at US$561.4 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$604.6 Million by the year 2030 trailing a CAGR of 17.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.1% and 14% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 13.3% CAGR.
Key Attributes:
Report Attribute
Details
No. of Pages
411
Forecast Period
2022 - 2030
Estimated Market Value (USD) in 2022
$1.6 Billion
Forecasted Market Value (USD) by 2030
$4.7 Billion
Compound Annual Growth Rate
14.4%
Regions Covered
Global
MARKET OVERVIEW
Pivotal Role of eCOA, ePRO and Patient Engagement in Transforming Patient Centricity
An Introduction to ePRO, E-Patient Diaries and eCOA
Pandemic Jolt Brings Strategic & Lasting Changes to Healthcare Sector
COVID-19 Expedites Healthcare Ecosystem's Evolution for Better Care & Cost Savings
Adoption of Telemedicine Services Accelerates Amidst the Pandemic
Pandemic Impact on eCOA, ePRO Market
COVID-19 Outbreak Compels Clinical Trials Industry to Move Towards ePRO
eCOA Solutions Help Address Hurdles Due to COVID-19 Pandemic
eCOA Playing a Part in Development of COVID-19 VaccineCOVID-19 Vaccine
Global Market Outlook
eCOA: The Largest Category
ePRO Offers Tremendous Opportunities in Improving Healthcare System
Competition
Competitive Market Presence - Strong/Active/Niche for Players Worldwide in 2023 (E)
Recent Market Activity
MARKET TRENDS & DRIVERS
Digitalization of Healthcare Services and Rising Importance of Electronic Data Capture Technologies to Fuel Market Growth
Patient Engagement Practices of the Future to be Shaped by Trends of Increased Use of Personal Devices and Passive Data
Key Patient Engagement Technology Trends and Innovations
eCOA & ePRO: A Powerful Duo Serving Clinical Trials with Electronic Data Collection
Rise in Clinical Trials Drives Need for ePRO, ePatient Diaries, and eCOA Solutions
COVID-19 Pandemic Triggers Technology Adoption in Clinical Trials
Trends in Clinical Trials Space to Influence Market Demand
Clinical Trials Increasingly Embraced Technology During COVID-19 Pandemic
Shift towards Decentralized/Virtual Clinical Trials to Boost Market Prospects
Decentralized Clinical Trials Driving Greater Demand for Patient-Centric Drug Development
Role of eCOA & ePRO in Enhancing Data Accuracy of Decentralized Clinical Trials
Growing Volumes of Data Generation in Decentralized Trials: A Challenge
Adoption of Digital Technologies in Contract Research Organizations Bodes Well for the Market
COVID-19 and Implications for Drug Development Regulations & Processes
Rise in Telemedicine Services Present Market Opportunities
Growing Adoption of Mobile Technologies and BYOD Trend in Healthcare Industry Boosts Market Prospects
Electronic Patient Record (ePRO) Solutions Emerge as Ideal Replacements for Paper-Based PRO systems
Moving over Paper Pains & Mastering the Art of Real-Time Data Collection with ePRO
Delivering Better Data: A Key Benefit of ePRO
Factors Ensuring Success of ePRO Implementations
ePatient Reported Outcomes (PROs) Gain Importance in Oncology Studies
Advances in ePRO Technologies Promise Better Clinical Decision Making in Healthcare Systems
Integrating AI into ePRO Improves the Efficiency of ePRO Data Collection and Assessment
Data Integrity, Security & Privacy: Key Priorities for ePRO Solutions
Electronic Clinical Outcome Assessment Solution (eCOA) Market: Poised for Growth
eCOA Grants The Best Route to Improve Data Quality & Patient Experience for Clinical Trials
Benefits Offered by eCOA Systems over the Paper-Based Systems in Trials
How to Successfully Implement eCOA Systems in Clinical Trials?
New Technologies & Approaches with Potential to Augment Statistical Prowess of eCOA
Technological Trends Transforming eCOA Solutions Market
Future Trends in eCOA Market: A Review
eCOA Proves Beneficial in Addressing Clinical Trial Challenges During COVID-19 Pandemic
UAT, Challenges and Embedded UAT for eCOAs
Benefits of BYOD for eCOAs
E-Patient Diaries: Significant Advantages over Paper Diaries to Drive Market
Major Benefits of ePatient Diary
eCOA & ePRO to Help Mental Health Research Shed the Taboo Status & Move Forward
Intriguing Perks of eCOA & ePRO for Mental Health Research
Increase in Healthcare Spending to Propel Demand
Increasing Burden of Chronic Diseases and Focus on Drug Development, Therapies and Vaccines Boost Market
Challenges Facing Companies Implementing eCOA, ePRO & Patient-Centric Clinical Trials
FOCUS ON SELECT PLAYERS (Total 85 Featured)
Dassault Systemes SE (3DS)
Anju Software
ArisGlobal LLC
CliniOps Inc.,
Castor EDC
ClinCapture
Crucial Data Solutions
For more information about this report visit https://www.researchandmarkets.com/r/2dq4rn
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Targets
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.